Eli Lilly GLP-1 Foundayo pill approved for obesity
The US Food and Drug Administration has approved Eli LillyThe GLP-1 pill, the company said, is a major milestone for…
Novo Nordisk A/S
Novo Nordisk launches Wegovy subscription for GLP-1 anti-obesity drugs
Wegovy semaglutide tablets. Michael Siluk | Universal Image Group | fake images Nordisk on Tuesday launched a multi-month subscription program…
Stocks Soar on Hope for Iran War Resolution; In addition, Lilly suffers a big change in sleep disorders
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Danone to buy protein shake maker Huel as healthy nutrition craze drives shift in demand
Huel makes powdered vegan meal replacements, aimed at people who “consider themselves time poor” but want healthy, environmentally sustainable meals.…
Eli Lilly's obesity drug retatrutide passes late-stage diabetes trial
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
FDA approves high-dose version of Novo Nordisk's anti-obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, on February…
Stopping GLP-1 increases cardiovascular risks: study
In a pharmacy you see boxes of Ozempic and Wegovy manufactured by Novo Nordisk. Hollie Adams | Reuters A version…
Eli Lilly Stock Falls After Analyst's Bearish Call: Here's Our Take
Eli Lilly shares fell 6% on Tuesday and are on track for their worst day since February after a downgrade…
Novo Nordisk ends legal proceedings against Hims & Hers
Nordisk has dropped its legal case against telehealth provider him and her for patent infringement, after the two companies agreed…
Eli Lilly Launches Program to Increase Employer Coverage of Obesity Drugs
Eli Lilly On Thursday it launched a new program designed to help more employers cover obesity medications in the U.S.,…